Results 21 to 30 of about 4,829,888 (359)
A Review of FDA-Approved Antiparasitic Drugs in USA for Sheep and Goats: Their Synthesis and Pharmaceutical Use [PDF]
Trends in Pharmaceutical Sciences, 2023 This review describes the Food and Drug Administration (FDA)-approved antiparasitic drugs for sheep and goats in the USA updated to 2021. The emerging drug resistance is posing a significant burden for the treatment of parasitic infections in these small
Davide Benedetto Tiz, Črtomir Podlipnik
doaj +1 more source
Cell Reports, 2021 There is an urgent need for antivirals to treat the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To identify new candidates, we screen a repurposing library of ∼3,000 drugs.
M. Dittmar +16 more
semanticscholar +1 more source
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
International Journal of Biological Macromolecules, 2021 The infectious microscopic viruses invade living cells to reproduce themselves, and causes chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to death if not treated.
D. R. Tompa +3 more
semanticscholar +1 more source
FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
Pharmaceutics, 2022 This review describes the recently FDA-approved drugs (in the year 2022). Many of these products contain active moieties that FDA had not previously approved, either as a single ingredient or as part of a combination.
Davide Benedetto Tiz +5 more
doaj +1 more source
FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
Cancers, 2021 Simple Summary Hematological malignancies are diseases involving the abnormal production of blood cells. The aim of the study is to collect comprehensive information on new drugs used in the treatment of blood cancers which have introduced into therapy ...
Aleksandra Sochacka-Ćwikła +2 more
semanticscholar +1 more source
Patient-reported outcomes in breast cancer FDA drug labels and review documents
Journal of Patient-Reported Outcomes, 2021 Background Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast ...
Kyungwan Hong +3 more
doaj +1 more source
Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer. [PDF]
, 2015 BackgroundCompounded lomustine is used commonly in veterinary patients. However, the potential variability in these formulations is unknown and concern exists that compounded formulations of drugs may differ in potency from Food and Drug Administration ...
Burton, JH +5 more
core +2 more sources
Comput. Biol. Medicine, 2021 With numerous infections and fatalities, COVID-19 has wreaked havoc around the globe. The main protease (Mpro), which cleaves the polyprotein to form non-structural proteins, thereby helping in the replication of SARS-CoV-2, appears as an attractive ...
Abhik Kumar Ray +5 more
semanticscholar +1 more source
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.
Journal of Natural Products, 2020 This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016. For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the ...
D. Newman, G. Cragg
semanticscholar +1 more source
Saudi Pharmaceutical Journal, 2023 Aegle marmelos (L.) Correa is an Indian medicinal plant known for its vast therapeutic activities. In Ayurveda, the plant is known to balance “vata,” “pitta,” and “kapha” dosh.
Ritu Tiwari +7 more
doaj +1 more source